Panthera Biopartners
Ian Smith is a seasoned professional in the pharmaceutical and clinical research sectors, currently serving as Chairman at PharmaKure Limited and Chief Medical Officer at Panthera Biopartners, among other directorial positions. With extensive experience in providing consultancy for clinical trials and a strong background in global medical direction at Synexus Clinical Research Limited, Ian has been instrumental in fostering relationships with government and key opinion leaders. Ian's entrepreneurial spirit is reflected in the founding of Healthcare at Home, where guidance was provided to establish the Scientific Advisory Board. Ian Smith holds a B.Med.Sci(Hons) and M.B.,Ch.B. in Medicine from the University of Dundee and Manchester.
This person is not in any offices
Panthera Biopartners
1 followers
Panthera Biopartners, established in 2019, is a leading UK-based Site Management Organisation (SMO) specialising in patient recruitment and the execution of clinical trials across various therapeutic areas. Founded by Dr Ian Smith, the originator of Synexus, and Professor John Lyon, a former global executive at Covance, Panthera has rapidly expanded its network to include dedicated clinical trial sites in major UK cities such as Glasgow, London, Manchester, Preston, Sheffield and York The organisation's mission is to enhance healthcare accessibility by conducting clinical research that integrates diverse insights and expertise. Panthera is committed to maintaining rigorous ethical standards and contributing to medical advancements that positively impact health and well-being. Panthera's management team comprises experienced professionals with extensive knowledge in conducting clinical trials across multiple therapy areas and countries. Key figures include Dr Ian Smith (Co-Founder, Director, and Chief Medical Officer), Stuart Young (Chief Executive Officer), and Chris Dodd (Chief Commercial Officer). In October 2024, Panthera became the first UK clinical trial site organisation to join Parexel’s Site Alliance Vaccine Network, a global consortium of high-performing clinical trial sites. This collaboration underscores Panthera's exceptional performance in patient recruitment and its strong partnership with Parexel. Panthera's dedication to innovation and excellence was recognised in October 2023 when it was named Pharma Research Centre of the Year at the Pharma Industry Awards UK. The award highlighted Panthera's innovative SMO model, which emphasises rapid start-up times, access to a vast pool of prequalified patients, and the digitisation of patient engagement processes.